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Abstract
Background: Transposon-mediated, non-viral gene delivery is a powerful tool for generating stable cell lines and
transgenic animals. However, as multi-copy insertion is the preferred integration pattern, there is the potential for
uncontrolled changes in endogenous gene expression and detrimental effects in cells or animals. Our group has
previously reported on the generation of several transgenic cattle by using microinjection of the Sleeping Beauty
(SB) and PiggyBac (PB) transposons and seeks to explore the long-term effects of this technology on cattle.
Results: Transgenic cattle, one female (SNU-SB-1) and one male (SNU-PB-1), reached over 36 months of age with
no significant health issues and normal blood parameters. The detection of transgene integration and fluorescent
signal in oocytes and sperm suggested the capacity for germline transmission in both of the founder animals. After
natural breeding, the founder transgenic cow delivered a male calf and secreted milk containing fluorescent
transgenic proteins. The calf expressed green fluorescent protein in primary cells from ear skin, with no significant
change in overall genomic stability and blood parameters. Three sites of transgene integration were identified by
next-generation sequencing of the calf’s genome.
Conclusions: Overall, these data demonstrate that transposon-mediated transgenesis can be applied to cattle without
being detrimental to their long-term genomic stability or general health. We further suggest that this technology may
be usefully applied in other fields, such as the generation of transgenic animal models.
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Background
Transposon-mediated gene delivery is a valuable tech-
nique for use in gene therapy and ex vivo gene delivery
and for in vitro cell line and animal model generations
[1–4]. Of the several DNA transposons available, Sleep-
ing Beauty (SB) and PiggyBac (PB) transposons have
been the most widely used to deliver exogenous genes
into cell lines and to generate transgenic animals. In
mice and rats, it is well established that transposon-
mediated transgenesis can result in germline transmis-
sion to create transgenic offspring. Transposons such as
SB and PB have also been used successfully to produce
transgenic pigs, sheep, goats and cattle [5–10], and in
the case of the transgenic pigs, germline transmission
was also observed [11].
The transposon system is particularly valuable as it
mediates both the efficient genomic integration and
stable expression of transgenes in target cells or animals.
The transposase enzyme binds specifically to the recog-
nition sequences of the transposon and induces the ‘cut-
and-paste’ integration of a transposon vector into the
genome in a site-specific manner (SB integrates at TA
sequences and PB integrates at TTAA) free from vector
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backbone DNA [12]. This system can be used in con-
junction with various non-viral delivery systems, such as
chemical-based transfection, electroporation or micro-
injection. In comparison to viral delivery and transgene
integration systems, transposon systems are more secure
and safe to use [13, 14] and this has led to NIH-OBA
and FDA approval for testing of the SB transposon in
humans [15–17].
In vitro studies have shown that the random nature of
SB and PB insertion events can lead to insertional muta-
genesis [4, 18]. However, as transposon-mediated gene
transfers can also integrate within non-coding regions,
the system is still considered far safer than viral delivery
systems in terms of potential geno-toxicity. In support
of this, our study on transgene integration sites in trans-
genic cattle demonstrated that all transgenes were inte-
grated within non-coding and non-functional regions
[5]. However, such genomic analyses may not be entirely
predictive of general health in transgenic animals.
Although transgenic cattle have been generated via
transposon-, viral vector- or somatic cell nuclear
transfer-mediated gene transfers, to date there has been
no report on long-term monitoring of health issues in
such cattle or their offspring. Therefore, we have sought
to test our hypothesis that multi-copy transgene integra-
tion in transgenic cattle (founders) will not affect their




All the transgenic cattle involved in this study were re-
ported in our previous publication [5]. Briefly, the trans-
genic cattle (females SNU-SB-1 and SNU-PB-2, and
male SNU-PB-1) were derived from embryos which had
undergone microinjection in order to introduce either of
the two transposon systems (SB or PB) as indicated.
Cell isolation and culture
Primary cultures of fibroblasts were derived from ear skin
biopsies of transgenic cattle. The ear skin was cut into
pieces of 1–4 mm in size with a sterile scalpel before being
washed several times and incubated at 37 °C for 16 h in
HBSS supplemented with collagenase (Collagenase type
IV, Gibco). The dispersed cells were washed in HBSS and
cultured in DMEM supplemented with antibiotics and
10% fetal calf serum.
Semen collection and freezing
Semen from the male transgenic founder was collected
using an artificial vagina (Fujihira Industry, Tokyo, Japan)
containing warm water at 50–55 °C. The collected semen
was immediately transported to the laboratory for freez-
ing. The semen was diluted 1:1 with OPTIXcell (IVM
technologies, France) and incubated at room temperature
for 10 min. The semen was further diluted 1:1 to a sperm
concentration of around 5.0 × 107 cells/mL before
incubation at 4 °C for 2 h. The concentrated sperm
solution was loaded into a 500 μL semen straw (IMV
technologies, France) and sealed with straw powder
(Fujihira Industry, Tokyo, Japan). The straw underwent
freezing 5.0 cm above the surface of liquid nitrogen for
30 min and was then plunged into a liquid nitrogen tank
for storage.
In vitro oocyte maturation, fertilization and culture of
embryos
Ovaries were obtained from a local abattoir and main-
tained in saline at 35 °C during transport to the laboratory.
Cumulus–oocyte complexes (COCs) from follicles 2 to
8 mm in diameter were aspirated using an 18-guage nee-
dle, selected and collected in a conical tube. The sediment
was washed three times with HEPES-buffered tissue
culture medium-199 (TCM-199; Invitrogen, Carlsbad,
CA, USA) supplemented with 2 mM NaHCO3 (Sigma–
Aldrich Corp., St. Louis, MO, USA), 10% FBS and 1%
penicillin–streptomycin (v/v). For in vitro maturation,
COCs were cultured for 22 h in 450 μL TCM-199 supple-
mented with 0.005 AU/mL FSH (Sigma–Aldrich), 10%
FBS, 1 μg/mL 17β-estradiol (Sigma–Aldrich) and 100 μM
Cysteamine (Sigma-Aldrich) at 39 °C under 5% CO2.
The Percoll gradient method for the separation and
purification of motile spermatozoa has been described in
detail elsewhere [19]. Briefly, spermatozoa were purified
from thawed semen straws by density-gradient centrifu-
gation on a Percoll discontinuous gradient (45–90%) at
1500 rpm for 15 min. The Percoll density gradient was
prepared by layering 1 mL of 45% Percoll solution onto
1 mL of 90% Percoll solution in a 15 mL conical tube.
The thawed semen was layered onto the top of the
Percoll gradient solution and the tube was centrifuged.
The pellet was washed twice with TALP by centrifuga-
tion for 5 min at 1500 rpm. The active, motile spermato-
zoa from the pellet were added to droplets containing
matured oocytes. Oocytes were inseminated on day 0
with 1–2 × 106 spermatozoa/mL for 18 h in IVF-TALP
medium (Nutricell) under mineral oil. The fertilized oo-
cytes were denuded and cultured in two-step defined
culture medium (5 days in D1 medium before transfer
to D2 medium) at 39 °C in an atmosphere of 5% O2, 5%
CO2 and 90% N2 [20].
Blood analysis and veterinary care
A veterinarian collected 5 ml whole blood samples from
the jugular vein for blood analysis and monitored regu-
larly general health condition. Some were used for
Complete Blood Count (CBC) (Hemavet 950, Drew
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Scientific, USA) and the others were used for serum
chemistry analysis (BS-400, Mindray, China).
One transgenic cow (SNU-PB-2) was injured by other
cattle, leading to severe respiratory distress. Under the
advice of veterinarians, we decided to euthanize the cow.
The planned method of euthanasia was administration
of a general anesthetic reagent before the use of pento-
barbital. However, due to severe organ damage caused
by the respiratory distress, only the general anesthetic
(Xylazine, BAYER; 0.15 mg/kg intravenous) was admin-
istered to be euthanasia.
Library preparation for massively parallel sequencing
Purified genomic DNA from F0 (SNU-SB-1, SNU-PB-1)
samples and the SNU-F1–1 sample was randomly sheared
using a Covaris S2 Ultrasonicator to yield DNA fragments
of on average 350 bp in size. Library preparation was per-
formed using the Illumina TruSeq DNA PCR-free prepar-
ation kit. Adaptor enrichments were performed using
PCR according to the manufacturer’s instructions. The
final library size and quality were evaluated by electro-
phoresis using an Agilent High Sensitivity DNA kit. The
150 bp paired-end reads were sequenced with an Illumina
HiSeq 4000 platform. Further image analysis and base
calling were performed with RTA 2.7.3 (Real Time
Analysis) and bcl2fastq v2.17.1.14.
Read alignment
Sequenced reads were filtered using sickle (v1.33) with a
Phred quality threshold of 20 to derive high-quality
reads. The remaining reads were mapped against the Bos
taurus genome (UMD 3.1, http://asia.ensembl.org/Bos_
taurus/Info/Annotation) and the transgene sequence
simultaneously using BWA ver. 0.7.5a. After mapping,
duplicates were marked using Picard ver. 1.128 and local
realignment was then performed using GATK ver. 3.6–0.
Variant analysis
Multi-sample calling (including F0 samples) of single
nucleotide variants (SNV) and insertions and deletions
(INDELs) was performed using GATK ver.3.6–0 with
UnifiedGenotyper. After multi-sample calling, variants
were filtered using a genotype quality value cutoff of 60.
The SnpEff software was used together with the UMD3.
1.79 Bos taurus Ensembl annotation set to predict the
functional effects of the variants detected.
Assessment of genomic stability
In order to investigate potential genomic instability, we
classified SNPs and INDELs into three groups: RefHom
(homozygous reference genotype), Hetero (heterozygous
genotype) and AltHom (homozygous alteration geno-
type). Genetic variants (SNPs and INDELs) were
assigned using the following criteria: (1) if the sequence
is classified as RefHom, the ratio to the reference allele
depth was more than 90%; (2) if the sequence is classi-
fied as Hetero, the ratio to the reference allele depth was
more than 40% and less than 60%; (3) if the sequence is
classified as AltHom, the ratio to the altered allele depth
was more than 90%. We also removed the mitochondrial
genome, X chromosome and unanchored scaffolds from
further analysis. Finally, we searched remaining variants
as de novo mutations rather than inherited sequences.
Identification of copy number variations (CNVs)
The Control-FREEC software was applied for the
identification of copy number changes in the genomes
of the transgenic cattle. The software is used for cal-
culation of the ploidy of regions of interest, with the
copy number value calculated for a 50 kb window in
the region of interest, following GC content read
count normalization, and compared to a normal auto-
somal ploidy value of two.
Detection of transgene insertion sites
Transgene insertion sites were identified some soft-
clipped nucleotide following mapping with BWA. Some
soft-clipped nucleotides could be determined by a
Smith-Waterman-like scoring scheme in the BWA soft-
ware. The candidate insertion sites were inferred by in-
spection of the mapped pattern in the soft-clipped
sequences. Delly software was also applied in parallel for
estimation of genomic structural variation as an indica-
tor of transgene insertion. Finally, we manually inspected
the candidate sites with IGV software.
Calculation of telomere length using the whole genome
sequence
Reads that were rich in telomere sequences were ex-
tracted from the whole genome sequence dataset and
their relative length determined. We then applied TelSeq
software to reveal any difference in the number of copies
of TTAGGG between transgenic and control genomes
through calculation of the frequency of reads.
Measurement of fluorescence intensity
To quantify the fluorescence intensities of samples from
SNU-F1–1 and SNU-F1–2, images of cells of the same
passage and density were acquired. Using ImageJ (v1.50,
NIH), an equally-sized region was selected using the
square-drawing function of the drawing/selection tools
and pixel measurements (area, mean gray value and in-
tegrated density) acquired from this region of interest.
The integrated density for each cell was calculated for
the region of interest.
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Results
Health monitoring using blood analysis
Both female (SNU-SB-1) and male (SNU-PB-1) transgenic
cattle reached ages of 50 and 43 months, respectively,
without any health problems (Fig. 1). Analysis of blood pa-
rameters (white blood cells, WBC; red blood cells, RBC;
platelets) showed no significant difference between the
blood of the transgenic animals and that of the reference
(Fig. 2). Furthermore, there was no significant difference
in various serum chemical parameters, including alanine
transaminase (ALT), aspartate transaminase (AST), and
blood urea nitrogen (BUN), between the transgenic ani-
mals and the reference (Additional file 1).
Germline transmission of the transgene
To assess the germline transmission in sperm of trans-
genes introduced by transposons, sperm was harvested
from SNU-PB-1 after puberty using manual ejaculation
and cryopreserved to create frozen semen stocks. Over
200 straws were produced and preserved in liquid nitro-
gen for future use. The motility of frozen-thawed semen
was normal, and the semen was used for in vitro
fertilization (IVF) together with wild-type oocytes.
Around 88% of blastocysts expressed green fluorescent
protein (GFP) in every round of IVF undertaken (Fig. 3).
Thus, the frozen sperm can be used to rapidly increase
the population of transgenic cattle. These results dem-
onstrate that germline transmission of transgenes intro-
duced by transposon systems is possible.
Natural birth of an F1 calf from transgenic cattle
SNU-SB-1 was mated naturally with SNU-PB-1 in order
to assess the stability of germline transmission of the
transgene to the resultant offspring. The F1 (SNU-F1–1,
male) was delivered without any assistance following the
gestation period (Fig. 4b) and a physical examination
concluded that there were no congenital defects. Expres-
sion of the GFP transgene in the eyes of the calf was ap-
parent without the use of equipment. To further
investigate the germline transmission of the transgene,
skin fibroblasts were isolated from SNU-F1–1, cultured
and expanded for genomic analysis. All of the fibroblasts
homogenously expressed GFP (Fig. 4c) and PCR analysis
of the genomic DNA from these cells demonstrated the
presence of GFP transgenes in the genome (Fig. 4d). The
construct integrated into the genome of the SNU-PB-1
father contained rox-flanked (froxed) GFP followed by
red fluorescent protein (RFP) [5]. We therefore expected
that if the same parental transgenes had been successfully
transmitted to SNU-F1–1, the expression of Dre recom-
binase should excise the froxed GFP from the genome,
leaving only a single rox site and RFP in the genome
(Fig. 4a). As expected, electroporation of Dre recombinase
into cells from SNU-F1–1 was sufficient to induce the
expression of RFP and the deletion of froxed GFP was
confirmed by PCR analysis (Fig. 4c–d). In contrast, we did
not detect transmission of yellow fluorescent protein
(YFP) transgenes from the mother (Additional file 2:
Figure S1). These data indicate the successful transmission
of transgenes from SNU-PB-1 to F1 offspring. Further-
more, the F1 calf SNU-F1–1 was healthy, with no signifi-
cant abnormalities detected by blood analysis (Fig. 2).
We examined wild-type milk and transgenic milk by
confocal microscopy to determine whether the trans-
genic fluorescent protein would be detected in milk
from SNU-SB-1 after delivery of SNU-F1–1. As ex-
pected, YFP was observed in the milk from SNU-SB-1
(Additional file 3: Figure S2). This result suggests that
transposon-derived transgenic cattle can be used as bio-
reactors for the production of recombinant proteins.
Fig. 1 Overview of transposon-derived transgenic cattle in this study. a Summary of transgene and general information for the transgenic cattle.
b Recent images of the transgenic cattle. Left: SNU-SB-1; right: SNU-PB-1
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Whole genome sequencing to determine integration sites
and genomic stability
To confirm the integration sites of the transgenes within
the maternal and paternal genomes, whole genome se-
quencing was performed with next-generation sequen-
cing (NGS). NGS has been widely used for high-
throughput genomic analysis, such as molecular
characterization and structure variation. We confirmed
the transgene insertion sites previously identified in the
F0 transgenic cattle [5, 21]. NGS of the SNU-F1–1 gen-
ome was performed to determine the transgene insertion
sites. The sequencing showed that a total of three copies
of the paternal transgene were transmitted to the F1 calf,
and we determined the sites of integration for the trans-
genes to be in non-coding regions (Table 1). Transgene
insertion sites were verified by 5′ junction sequence ana-
lysis using a specific primer set that anneals to the
unique genome-to-transposon junction in chromosomes
Fig. 2 Analysis of blood parameters from three transgenic cattle (SNU-SB-1, SNU-PB-1 and SNU-F1–1). Samples were collected three times at
different ages. One sample for counting of WBC from SNU-SB-1 failed due to blood coagulation, but chemical analysis of the serum was performed as
planned (see Additional file 1). Circles indicate dates of blood collection and analysis; Orange circle: 26/08/2016; Blue circle: 26/10/2016; Gray circle:
27/03/2017; WBC: White blood cells; RBC: Red blood cells; Gray box: reference range
Fig. 3 Germline transmission of transgenes in spermatozoa from SNU-PB-1. Blastocyst stage embryos express GFP after IVF using frozen-thawed
semen from SNU-PB-1. BF: bright field; GFP: GFP field
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Fig. 4 Detection of transgene expression in SNU-F1–1. a Schematic of Dre-rox recombination in constructs used in this study. b Image of SNU-
F1–1 (left) and its mother, SNU-SB-1 (right). c Primary cells from the ear skin of SNU-F1–1 express the transgenic reporter protein, GFP (upper).
RFP expression is detected following transfection of ear skin cells with Dre recombinase (lower). d PCR analysis of Dre-rox recombination using
genomic DNA from the cells derived from SNU-F1–1. P/C, positive control (PB-CA-Rox-GFP-Rox-RFP vector); WT, genomic DNA from wild type
cattle; Tg:SNU-PB-1, genomic DNA from the blood of SNU-PB-1; Tg:SNU-F1–1, genomic DNA from the blood of SNU-F1–1; Tg:SNU-F1–1 + Dre,
genomic DNA from cells from SNU-F1–1 which have undergone transfection with Dre recombinase; N/C, negative control (nuclease-free water)
Table 1 All integration sites in SNU-F1–1
No. Chromosome Insertion site Orientation 5′ gene 3′ gene
1 4 95,433,564–95,434,563 Forward TSGA13 MKLN1
2 4 113,823,097–113,823,101 Forward ENSBTAG00000001198.5 ENSBTAG00000046257.1
3 6 20,085,913–20,086,912 Forward DKK2 GIMD1
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4 (two sites) and 6 (Additional file 4: Figure S3).
Additionally, we compared the genome of SNU-F1–1 to
those of its parents (F0 samples) and identified 147 het-
erozygous de novo mutations and 2 homozygous de
novo mutations differing from the maternal and paternal
genomes (Table 2). The heterozygous de novo mutations
were classified by position into intergenic (125, 78.61%),
intronic (33, 20.76%) and exonic (1, 0.63%, in the
ENSBTAG00000038261 gene) mutations, with most
occurring in the intergenic and intronic regions. In
addition, the homozygous de novo mutations were identified
mistaken searched variants because they occurred in the
long terminal repeat (LTR) region. The number of de novo
mutations is consistent with previous studies [22], corre-
sponding to a mutation rate of 5.62 × 10− 8 per position per
generation per genome. And then, we identified the
telomere length is 10.23. We have summarized the SNVs,
INDELs and CNVs detected (Fig. 5).
Correlation of GFP expression level with transgene copy
number
There are several studies which demonstrate a correl-
ation between the level of protein expression and trans-
gene copy number [23, 24]. To investigate the
relationship between GFP expression level and transgene
copy number, we analyzed the skin fibroblasts from
SNU-F1–1 and fetal fibroblasts derived from the fetus
(SNU-F1–2) of another pregnant transgenic animal,
SNU-PB-2 [5]. SNU-PB-2 became pregnant but was
gravely injured by other cattle and had to be euthanized.
Fluorescent signal was confirmed in the recovered uterus,
ovary and oocytes of SNU-PB-2 (Additional file 5:
Figure S4). NGS analysis of the genome of SNU-F1–2
identified six transgene integration sites and no genomic
instability (Additional file 6: Table S1 and Additional file 7:
Figure S5). Both SNU-F1–1 and SNU-F1–2 were gener-
ated from a single embryo and there was no mosaicism.
As expected, cells from SNU-F1–2 (six copies) showed an
approximately 2.2-fold higher expression level of GFP
compared to cells from SNU-F1–1 (three copies) (Fig. 6).
This result confirms previous work showing that trans-
gene copy number is an important factor to determine the
level of transgenic protein expression in transgenic cattle.
Discussion
Transgenesis in cattle shows great promise for providing
insights into basic embryogenesis and disease mecha-
nisms (through the creation of disease models), as well




Yellow box: heterozygous de novo mutation not detected in parental DNA
Red box: homozygous de novo mutation not detected in parental DNA
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as clear potential for protein production and isolation
through using cattle as bioreactors. Thus it has long
been of interest as a biotechnology in agricultural and
veterinary science. However, its progress has been ham-
pered at the practical level by a low efficiency of gene
delivery, abnormal reprogramming in cloned embryos
and a low success rate for obtaining cloned transgenic
offspring with frequent complications (i.e., early embry-
onic loss and sudden death) [25, 26].
Transposon systems have been extensively applied
when generating transgenic animal models and have
been successfully utilized in zebrafish [27], mice [28],
rats [29], pigs [30] and cattle [7]. Moreover, previous
studies have verified germline transmission when using
transposons in transgenic zebrafish [31], rodents [32, 33]
and pigs [6, 11]. As cattle have a long gestational term
and time to puberty, there has only been one previous
study, which used lentivirus-mediated transgenesis, to
investigate germline transmission in transgenic cattle
[34]. In the present study, we have demonstrated that
both female and male transgenic cattle with multi-copy
integration of transposon-derived transgenes can reach
maturity without health issues and we have verified
germline transmission through the inheritance of their
transgenes by the F1 generation.
Due to the cut-and-paste action of DNA transposons,
it has long been presumed that transposon-mediated
transgenesis could create additional genomic instability
[1, 35]. However, many studies have demonstrated that
transposons can be used safely and without inducing
genomic instability [5, 6, 29, 36–38]. Additionally, in our
previous report, all transgenes inserted using either SB
or PB in multiple cattle were found to be integrated into
non-coding regions. Consistent with previous reports
[38], there was no significant difference between the
SNU-F1–1 offspring and its parents in terms of SNP,
CNV, structural variation (SV) or telomere length as
assessed by NGS analysis (Fig. 5). Transgene integration
sites were identified in three loci in SNU-F1–1 via NGS
analysis (Table 1), and were determined to be only from
the paternal genome (SNU-PB-1). As the transgenes in-
tegrated into the maternal genome (SNU-SB-1) were
Fig. 5 Overview of genomic variation in SNU-F1–1. Reference chromosomes from bt1 to btX are denoted by colored boxes at the outer edge.
Plots denoting copy number variation (CNV; black dot plots in the green area), coverage (green line plot in the green area) and SNP density
(orange histogram in orange area) for the SNU-F1–1 genome are shown for each 10 kb window
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heterozygous, it is possible that, following haploid cell
generation, an oocyte lacking transgenes was fertilized by
the sperm containing the GFP transgenes. As in our previ-
ous report, we found that the transgenes in the offspring
(SNU-F1–1) were integrated into sites bearing the PB pre-
ferred integration sequence, “TTAA” (Additional file 4:
Figure S3) [5]. Two integration sites were identical to
those seen in SNU-PB-1. One site was not identified in
our previous report investigating integration sites in the
paternal genome, possibly because that analysis was per-
formed on material from the blood [5] and did not assess
integration sites in other organs, such as the testes.
This report also demonstrates that transgenic cattle
can act as potential bioreactors for the secretion of ex-
ogenous proteins in milk [39–41], as we identified the
production of YFP in milk from SNU-SB-1 (Additional
file 3: Figure S2). Further, SNU-F1–1 was fed the YFP-
containing milk from SNU-SB-1 for 7 months until
weaning. We note that even though the calf consumed
milk containing fluorescent proteins for a long period, it
has not shown any health issues to date, and so conclude
that consumption of transgenic fluorescent protein does
not affect health.
The position of the transgene integration site within the
genome determines its level of expression or silencing, an
effect illustrated by the mosaicism seen during germline
transmission in transgenic mice derived from viral-
mediated gene transfer [42–45], and so the copy number
becomes an important determinant of the expression of
the transgene. This is a particularly important consider-
ation in transposon-derived transgenic cattle, given their
potential use as bioreactor models. Of the cattle derived
from germline-transmission of the transgene, SNU-F1–1
and SNU-F1–2 have three and six copies of integrated
transgenes, respectively; this allowed an indirect analysis
of the relationship between copy number and expression
levels in these animals. Although only two samples,
we note that the expression level of the transgene in
SNU-F1–2 was almost 2.2-fold higher than in SNU-F1–1,
indicating that in this case transposon-mediated integra-
tion was not affected by silencing or mosaicism.
Our analysis of transgene expression levels in SNU-F1–1
and SNU-F1–2 suggest that the sites of integration in
these animals are valuable positions for targeted genome
engineering, as we have not observed effects relating to
neighboring gene expression or silencing. Therefore, the
transgene integration sites identified in SNU-F1–1 will be
used for targeted gene expression studies of site-specific
knock-in (KI) transgenesis using the CRISPR/Cas9 system.
As a proof of principle for this approach, SNU-F1–1 cells
were transfected with a single guide RNA targeting GFP,
the Cas9 enzyme and a KI donor template that includes
RFP and puromycin resistance transgenes between the
homology arms. RFP signal was detected in cells following
transfection, suggesting effective targeting by CRISPR/
Cas9 (Additional file 8: Figure S6). In addition, we will also
investigate whether the transgenes of the F1 generation
will again be transmitted to the next generation (F2) and
whether the integration sites are altered or remain stable
for future generations.
A further issue that we have attempted to address in
this study is whether long-term, stable expression of the
Fig. 6 Expression level of GFP in cells from SNU-F1–1 and SNU-F1–2. Brightfield and fluorescent images of cells from SNU-F1–1 (upper) and SNU-
F1–2 (lower). GFP: GFP field
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fluorescent protein in our transgenic cattle (SNU-SB-1,
SNU-PB-1, and SNU-F1–1) causes health problems, as
GFP has the potential for immunogenicity and cytotox-
icity [46]. Female SNU-SB-1, male SNU-PB-1 and F1 calf
SNU-F1–1 (male) have all reached maturity at ages of
50, 43 and 19 months old, respectively, and have no gen-
eral health problems (feeding, growth, body weight, urin-
ation or defecation). As further evidence of their health
there were no significant abnormalities detected by regu-
lar blood analysis (Fig. 2, Additional file 1). These results
indicate that transposon-mediated multi-gene integra-
tion into the bovine genome and continuous transgene
expression does not adversely affect health, for example
in organ growth or function. Some RBC, hemoglobin,
and hematocrit values in SNU-F1–1 were outside of the
reference range (Fig. 2). As previously noted [47], this is
most likely due to the age at which blood was collected
from the calf, namely at 2 and 10 weeks old. As the gen-
etic variants in SNU-SB-1 and SNU-PB-1 are not signifi-
cantly different from wild-type cattle, as shown in a
previous NGS analysis [5], and the genomic stability
(SNP, INDEL and telomere length, etc.) of SNU-F1–1
was not significantly affected (Fig. 5), it is perhaps un-
surprising that the cattle generated are healthy. We will
continue to monitor their longevity and health status.
To our knowledge, this is the first report of transposon-
derived transgenic cattle surviving for this length of time
without any health issues.
Conclusions
In this study we have demonstrated that multi-copy
transgenic cattle derived using the SB and PB systems
have survived for more than 3 years without any health
issues, and we show for the first time that their trans-
genes were stably transmitted through the germline to
the next generation. The transgenic calf derived through
germline transmission has reached maturity at over
19 months old and is healthy, with no significant abnor-
malities detected by analyses of blood parameters and
genomic stability. In conclusion, our study provides
valuable data about the safety and long-term expression
of transgenes in cattle using transposon-mediated gene
modification, and its utility in applications such as ex-
ogenous protein expression.
Additional files
Additional file 1: Raw data of blood analysis from transgenic cattle.
(XLSX 15 kb)
Additional file 2: Figure S1. SNU-F1–1 lacks the YFP transgene, as
demonstrated by PCR analysis of genomic DNA from SNU-F1–1. PCR was
performed using YFP-specific primers. P/C, positive control (SB-CA-YFP
vector); WT, genomic DNA from wild type cattle; Tg:SNU-SB-1, genomic
DNA from the blood of SNU-SB-1; Tg:SNU-F1–1, genomic DNA from the
blood of SNU-F1–1; N/C, negative control (nuclease-free water). (PNG 99 kb)
Additional file 3: Figure S2. Detection of the expression of YFP in milk
from SNU-SB-1 by confocal microscopy. Images of milk from wild type
cattle (left) and SNU-SB-1 (right) taken using a high-throughput confocal
microscope. YFP: YFP field. (PNG 1685 kb)
Additional file 4: Figure S3. 5′ junction sequence analysis of all
integration sites in SNU-F1–1. Sequences showing the genome-to-
transposon junctions in the genome of SNU-F1–1 and the integration of
transgenes at TTAA sites. (PNG 465 kb)
Additional file 5: Figure S4. Germline transmission of GFP expression
in uterus, ovary and oocytes from SNU-PB-2. Fluorescent microscope
images of GFP expression in: a) uterus from SNU-PB-2, b) ovaries (WT, left;
SNU-PB-2, right and arrow) and c) oocytes and cumulus cells from SNU-
PB-2. (PNG 1557 kb)
Additional file 6: Table S1. All transgene integration sites in SNU-F1–2.
(DOCX 24 kb)
Additional file 7: Figure S5. Overview of genomic variation in SNU-F1–2.
Reference chromosomes from bt1 to btX are denoted by colored boxes at
the outer edge. Plots denoting copy number variation (CNV; black dot plots
in the green area), coverage (green line plot in the green area) and SNP
density (orange histogram in orange area) for the SNU-F1–2 genome are
shown for each 10 kb window. (PNG 1244 kb)
Additional file 8: Figure S6. CRISPR/Cas9-mediated KI in SNU-F1–1
cells. (a) Schematic of CRISPR/Cas9-mediated KI of the donor construct.
(b) SNU-F1–1 cells were co-transfected with the donor plasmid, Cas9 and
sgRNA targeting GFP. The detection of RFP signal and loss of GFP signal
in these cells suggests that CRISPR/Cas9-mediated homology directed
repair has occurred. pCAG: CAGGS promoter; HA: homology arm; BF:
brightfield; GFP: GFP field; RFP: RFP field. (PNG 491 kb)
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